Urogenital sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JCS), The Japanese Association for Infectious Diseases (JAID) and The Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan.
J Infect Chemother. 2013 Jun;19(3):393-403. doi: 10.1007/s10156-013-0606-9. Epub 2013 May 3.
The Japanese surveillance committee conducted the first nationwide surveillance of antimicrobial susceptibility patterns of uropathogens responsible for female acute uncomplicated cystitis at 43 hospitals throughout Japan from April 2009 to November 2010. In this study, the causative bacteria (Escherichia coli and Staphylococcus saprophyticus) and their susceptibility to various antimicrobial agents were investigated by isolation and culturing of bacteria from urine samples. In total, 387 strains were isolated from 461 patients, including E. coli (n = 301, 77.8 %), S. saprophyticus (n = 20, 5.2 %), Klebsiella pneumoniae (n = 13, 3.4 %), and Enterococcus faecalis (n = 11, 2.8 %). S. saprophyticus was significantly more common in premenopausal women (P = 0.00095). The minimum inhibitory concentrations of 19 antibacterial agents used for these strains were determined according to the Clinical and Laboratory Standards Institute manual. At least 87 % of E. coli isolates showed susceptibility to fluoroquinolones and cephalosporins, and 100 % of S. saprophyticus isolates showed susceptibility to fluoroquinolones and aminoglycosides. The proportions of fluoroquinolone-resistant E. coli strains and extended-spectrum β-lactamase (ESBL)-producing E. coli strains were 13.3 % and 4.7 %, respectively. It is important to confirm the susceptibility of causative bacteria for optimal antimicrobial therapy, and empiric antimicrobial agents should be selected by considering patient characteristics and other factors. However, the number of isolates of fluoroquinolone-resistant or ESBL-producing strains in gram-negative bacilli may be increasing in patients with urinary tract infections (UTIs) in Japan. Therefore, these data present important information for the proper treatment of UTIs and will serve as a useful reference for future surveillance studies.
日本监测委员会于 2009 年 4 月至 2010 年 11 月在日本全国 43 家医院对导致女性急性单纯性膀胱炎的尿路病原体的抗菌药物敏感性模式进行了首次全国性监测。在这项研究中,通过从尿液样本中分离和培养细菌,调查了致病细菌(大肠埃希菌和腐生葡萄球菌)及其对各种抗菌药物的敏感性。总共从 461 名患者中分离出 387 株细菌,包括大肠埃希菌(n=301,77.8%)、腐生葡萄球菌(n=20,5.2%)、肺炎克雷伯菌(n=13,3.4%)和粪肠球菌(n=11,2.8%)。腐生葡萄球菌在绝经前妇女中更为常见(P=0.00095)。根据临床和实验室标准协会手册确定了这些菌株对 19 种抗菌药物的最小抑菌浓度。至少 87%的大肠埃希菌分离株对氟喹诺酮类和头孢菌素类药物敏感,100%的腐生葡萄球菌分离株对氟喹诺酮类和氨基糖苷类药物敏感。氟喹诺酮类耐药大肠埃希菌菌株和产超广谱β-内酰胺酶(ESBL)大肠埃希菌菌株的比例分别为 13.3%和 4.7%。确认病原体的敏感性对于最佳抗菌治疗非常重要,应根据患者特征和其他因素选择经验性抗菌药物。然而,日本尿路感染(UTI)患者中革兰氏阴性杆菌中氟喹诺酮类耐药或产 ESBL 菌株的数量可能在增加。因此,这些数据为正确治疗 UTI 提供了重要信息,并将为未来的监测研究提供有用的参考。